|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues | |||||
| Research and development expenses | |||||
| Sales and marketing | |||||
| Impairment of intangible asset | |||||
| Impairment of intangible assets | |||||
| General and administrative expenses | |||||
| Other income, net | |||||
| Operating loss | |||||
| Equity losses of an associate | |||||
| Gain from sale of an associate | |||||
| Finance income | |||||
| Finance expenses | |||||
| Loss before income taxes | |||||
| Taxes on income | |||||
| Net loss and total comprehensive loss | |||||
| Basic loss per ordinary share attributable to equity holders of the Company (in Dollars per share) | |||||
| Diluted loss per ordinary share attributable to equity holders of the Company (in Dollars per share) (in Dollars per share) | |||||
| Attributable to: | |||||
| Equity holders of the Company | |||||
| Non-controlling interests | |||||
Loading...